Molecular weight heparin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Blood Platelets

Organisms3

Rats, Sprague-Dawley Cattle Rabbits

Diseases26

Venous Thrombosis Venous Thromboembolism Hemorrhage Thromboembolism Thrombophlebitis Pulmonary Embolism Thrombosis Body Weight Angina, Unstable Thrombophilia Weight Loss Weight Gain Thrombocytopenia Postoperative Complications Pregnancy Complications, Cardiovascular Antiphospholipid Syndrome Blood Loss, Surgical Birth Weight Heart Valve Prolapse Recurrence Acute Disease Neoplasms Myocardial Infarction Disease Models, Animal Disseminated Intravascular Coagulation Pregnancy Complications, Hematologic

Chemicals and Drugs40

Heparin, Low-Molecular-Weight Dalteparin Nadroparin Anticoagulants Enoxaparin Heparin Factor Xa Heparin Antagonists Heparin Lyase Fibrinolytic Agents Antithrombins Antithrombin III Antithrombin Proteins Acenocoumarol Polysaccharides Factor IXa Warfarin Dermatan Sulfate Thrombin Glycosaminoglycans Hirudins Aspirin Platelet Aggregation Inhibitors Alloys Dextrans Heparitin Sulfate Capsules Fibrin Fibrinogen Degradation Products Prothrombin Fibrin Heparin Cofactor II Oligosaccharides Protamines Gelatin Platelet Glycoprotein GPIIb-IIIa Complex Placebos Amino Acids Macromolecular Substances Peptide Fragments Kininogens

Analytical, Diagnostic and Therapeutic Techniques and Equipment38

Thrombin Time Partial Thromboplastin Time Injections, Subcutaneous Body Weight Treatment Outcome Bandages Stockings, Compression Whole Blood Coagulation Time Blood Coagulation Tests Prothrombin Time Prospective Studies Administration, Cutaneous Birth Weight Electrophoresis, Polyacrylamide Gel Chromatography, Gel Double-Blind Method Drug Therapy, Combination Administration, Oral Random Allocation Placebos Infusions, Intravenous Randomized Controlled Trials as Topic Thrombolytic Therapy Risk Factors Pregnancy Outcome Drug Administration Schedule Disease Models, Animal Risk Assessment Follow-Up Studies Chromatography, Affinity Retrospective Studies Angioplasty, Balloon, Coronary Incidence Chromatography, Ion Exchange Chromatography Isoelectric Point Immunodiffusion Phlebography

Phenomena and Processes23

Molecular Weight Thrombin Time Partial Thromboplastin Time Blood Coagulation Body Weight Weight Loss Weight Gain Whole Blood Coagulation Time Dose-Response Relationship, Drug Prothrombin Time Kinetics Time Factors Birth Weight Pregnancy Particle Size Protein Binding Platelet Aggregation Amino Acid Sequence Pregnancy Outcome Hydrogen-Ion Concentration Isoelectric Point Base Sequence Substrate Specificity

Disciplines and Occupations1

Technology, Industry, Agriculture1

Information Science4

Amino Acid Sequence Molecular Sequence Data Incidence Base Sequence

Health Care11

Treatment Outcome Prospective Studies Double-Blind Method Random Allocation Randomized Controlled Trials as Topic Risk Factors Risk Assessment Follow-Up Studies Practice Guidelines as Topic Retrospective Studies Incidence

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Heparin, Low-Molecular-Weight Dalteparin Nadroparin Anticoagulants Enoxaparin Heparin Molecular Weight Factor Xa Heparin Antagonists Thrombin Time Venous Thrombosis Venous Thromboembolism Heparin Lyase Partial Thromboplastin Time Blood Coagulation Injections, Subcutaneous Fibrinolytic Agents Antithrombins Hemorrhage Thromboembolism Thrombophlebitis Pulmonary Embolism Antithrombin III Thrombosis Antithrombin Proteins Body Weight Acenocoumarol Polysaccharides Factor IXa Warfarin Dermatan Sulfate Thrombin Angina, Unstable Thrombophilia Weight Loss Treatment Outcome Weight Gain Bandages Glycosaminoglycans Hirudins Aspirin Thrombocytopenia Stockings, Compression Whole Blood Coagulation Time Blood Coagulation Tests Platelet Aggregation Inhibitors Dose-Response Relationship, Drug Postoperative Complications Alloys Prothrombin Time Dextrans Pregnancy Complications, Cardiovascular Kinetics Time Factors Prospective Studies Heparitin Sulfate Orthopedics Capsules Fibrin Fibrinogen Degradation Products Prothrombin Fibrin Heparin Cofactor II Antiphospholipid Syndrome Blood Loss, Surgical Administration, Cutaneous Birth Weight Heart Valve Prolapse Electrophoresis, Polyacrylamide Gel Oligosaccharides Recurrence Protamines Chromatography, Gel Pregnancy Double-Blind Method Drug Therapy, Combination Gelatin Particle Size Platelet Glycoprotein GPIIb-IIIa Complex Acute Disease Administration, Oral Neoplasms Myocardial Infarction Random Allocation Protein Binding Placebos Infusions, Intravenous Randomized Controlled Trials as Topic Amino Acids Platelet Aggregation Thrombolytic Therapy Blood Platelets Amino Acid Sequence Risk Factors Pregnancy Outcome Drug Administration Schedule Molecular Sequence Data Rats, Sprague-Dawley Disease Models, Animal Risk Assessment Follow-Up Studies

No FAQ available that match "molecular weight heparin"